Atreca Stock Quote Today

BCEL Stock  USD 1.58  0.00  0.00%   
Market Performance
4 of 100
Odds Of Distress
Less than 48
Atreca is selling for 1.58 as of the 27th of January 2023. This is a No Change since the beginning of the trading day. The stock's lowest day price was 1.54. Atreca has 48 percent odds of going through some form of financial distress in the next two years and did not have a very good performance for investor during the last 90 trading days. Equity ratings for Atreca Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of February 2021 and ending today, the 27th of January 2023. Click here to learn more.
Fiscal Year End
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
20th of June 2019
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Atreca, Inc. was incorporated in 2010 and is based in San Carlos, California. Atreca Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 32.35 M outstanding shares of which 2.46 M shares are currently shorted by private and institutional investors with about 14.11 trading days to cover. More on Atreca Inc

Moving against Atreca

-0.86PFEPfizer Inc Earnings Call This WeekPairCorr
-0.67LLYEli Lilly And Earnings Call This WeekPairCorr
-0.55MRKMerck Company Earnings Call This WeekPairCorr
-0.52GILDGilead Sciences Earnings Call This WeekPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Atreca Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Atreca's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Atreca or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Fama & French Classification
Average Analyst Recommendation
Analysts covering Atreca report their recommendations after researching Atreca's financial statements, talking to executives and customers, or listening in on Atreca's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Atreca Inc. The Atreca consensus assessment is calculated by taking the average forecast from all of the analysts covering Atreca.
Strong Buy7 Opinions
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Atreca Inc based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Atreca Inc financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares Diluted36 M33.3 M
Significantly Up
Slightly volatile
Weighted Average Shares36 M33.3 M
Significantly Up
Slightly volatile
Current Liabilities12.2 M15.2 M
Significantly Down
Slightly volatile
Total Liabilities43.8 M40.6 M
Significantly Up
Slightly volatile
Total Debt3.7 K3.6 K
Fairly Up
Slightly volatile
Current Assets116.6 M110.1 M
Notably Up
Slightly volatile
Total Assets164.3 M180.1 M
Significantly Down
Slightly volatile
Macroaxis Advice
The buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Atreca's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Cautious HoldUndervalued
Financial Strength
Atreca's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Atreca's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Atreca's financial leverage. It provides some insight into what part of Atreca's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Atreca's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Atreca deploys its capital and how much of that capital is borrowed.
Atreca cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 65.48 M in liabilities with Debt to Equity (D/E) ratio of 0.57, which is about average as compared to similar companies. Atreca Inc has a current ratio of 7.98, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Atreca until it has trouble settling it off, either with new capital or with free cash flow. So, Atreca's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Atreca Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Atreca to invest in growth at high rates of return. When we think about Atreca's use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

(75.59 Million)
Atreca Inc (BCEL) is traded on NASDAQ Exchange in USA and employs 91 people. Atreca is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 61.73 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Atreca's market, we take the total number of its shares issued and multiply it by Atreca's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Atreca Inc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 32.35 M outstanding shares of which 2.46 M shares are currently shorted by private and institutional investors with about 14.11 trading days to cover. Atreca Inc currently holds about 101.73 M in cash with (60.92 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.64, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Atreca Probability Of Bankruptcy
Atreca holds a total of thirty-two million three hundred fifty-two thousand outstanding shares. Over half of Atreca Inc outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulation than regular investors in Atreca. Please watch out for any change in the institutional holdings of Atreca Inc as this could mean something significant has changed or about to change at the company. Please note that no matter how much assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation

Check Atreca Ownership Details

Atreca Stock Price Odds Analysis

Based on a normal probability distribution, the odds of Atreca jumping above the current price in 90 days from now is about 12.05%. The Atreca Inc probability density function shows the probability of Atreca stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days the stock has a beta coefficient of 1.6737 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Atreca will likely underperform. Additionally, the company has an alpha of 0.0354, implying that it can generate a 0.0354 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 1.58HorizonTargetOdds Above 1.58
87.90%90 days
Based on a normal probability distribution, the odds of Atreca to move above the current price in 90 days from now is about 12.05 (This Atreca Inc probability density function shows the probability of Atreca Stock to fall within a particular range of prices over 90 days) .

Atreca Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Atreca that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Atreca's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Atreca's value.
InstituionSecurity TypeTotal SharesValue
Zurcher Kantonalbank Zurich CantonalbankCommon Shares2.9 K18 K
Zurcher Kantonalbank Zurich CantonalbankCommon Shares2.9 K24 K
View Atreca Diagnostics

Atreca Historical Income Statement

Atreca Inc Income Statement is one of the three primary financial statements used for reporting Atreca's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Atreca Inc revenue and expense. Atreca Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Atreca Interest Expense is relatively stable at the moment as compared to the past year. The company's current value of Interest Expense is estimated at 2,771. Weighted Average Shares is expected to hike to about 36 M this year, although the value of Earning Before Interest and Taxes EBIT will most likely fall to (106.2 M). View More Fundamentals

Atreca Stock Against Markets

Picking the right benchmark for Atreca stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Atreca stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Atreca is critical whether you are bullish or bearish towards Atreca Inc at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Atreca without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Fundamental Analysis Now


Fundamental Analysis

View fundamental data based on most recent published financial statements
All  Next Launch Module

Atreca Corporate Management

Elected by the shareholders, the Atreca's board of directors comprises two types of representatives: Atreca inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Atreca. The board's role is to monitor Atreca's management team and ensure that shareholders' interests are well served. Atreca's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Atreca's outside directors are responsible for providing unbiased perspectives on the board's policies.
Yann Tan - Chief TechnologistProfile
Herbert Cross - Chief OfficerProfile
Stephen Gould - Chief OfficerProfile
Tito Serafini - Chief FounderProfile
John Orwin - CEO PresProfile
Courtney JD - Gen SecProfile

Invested in Atreca Inc?

The danger of trading Atreca Inc is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Atreca is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Atreca. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Atreca Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. Note that the Atreca Inc information on this page should be used as a complementary analysis to other Atreca's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Atreca Stock analysis

When running Atreca Inc price analysis, check to measure Atreca's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atreca is operating at the current time. Most of Atreca's value examination focuses on studying past and present price action to predict the probability of Atreca's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Atreca's price. Additionally, you may evaluate how the addition of Atreca to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Fundamental Analysis
View fundamental data based on most recent published financial statements
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Is Atreca's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atreca. If investors know Atreca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atreca listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
61.7 M
Return On Assets
Return On Equity
The market value of Atreca Inc is measured differently than its book value, which is the value of Atreca that is recorded on the company's balance sheet. Investors also form their own opinion of Atreca's value that differs from its market value or its book value, called intrinsic value, which is Atreca's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atreca's market value can be influenced by many factors that don't directly affect Atreca's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atreca's value and its price as these two are different measures arrived at by different means. Investors typically determine Atreca value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atreca's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.